POSS改性复合树脂负载氯己定生物活性玻璃的抗菌性能增强
本研究将氯己定(CHX)负载于45S5生物活性玻璃(BG)并掺入含POSS纳米单体的树脂基质,制备新型抗菌牙科复合树脂。结果显示2% CHX负载时材料保持可接受力学性能,体外呈先快后慢的持续释放,具良好生物相容性及显著抗菌活性。
要点
- 2% CHX负载的POSS改性复合树脂兼具可接受力学性能与显著抗菌活性。
- CHX负载量增加会导致颗粒团聚、双键转化率下降和力学强度降低。
- 该材料体外释放呈初期快速后持续缓慢模式,体内外生物相容性良好。
核心结论
- 将2% CHX负载的45S5生物活性玻璃掺入POSS改性复合树脂,可保持可接受力学性能并提供持续释放、生物相容性和显著抗菌活性。
研究设计与样本
- 实验性复合树脂含20 wt% CHX负载BG 45S5和40 wt% SiO₂无机填料,基质含4 wt% POSS纳米单体。
- 采用FTIR和SEM表征材料并分析双键转化率,万能试验机评估力学性能,SEM分析断裂机制。
- 体外评估CHX释放行为,CCK-8、急性经口全身毒性试验和口腔黏膜刺激试验评估生物相容性。
- 采用细菌生长试验、琼脂平板计数和纸片扩散法评估抗菌活性。
主要发现
- 增加CHX浓度导致颗粒团聚、双键转化率降低和力学强度下降。
- C2与C0的压缩强度差异有统计学意义(p < 0.05),而弯曲强度无显著差异(p > 0.05)。
- CHX负载浓度为2%时复合树脂表现出可接受的力学性能。
- 体外药物释放显示初期快速释放阶段,随后为持续且较慢的释放。
- CCK-8显示C2在24、48和72 h的细胞活力与C0相当(p > 0.05),体内评估未见明显全身毒性或口腔黏膜刺激,C2较C0表现出显著抗菌活性(p < 0.05)。
关键数值与推荐
- 实验复合树脂配方:20 wt% CHX负载BG 45S5、40 wt% SiO₂、4 wt% POSS纳米单体。
- CHX负载浓度为2%时力学性能可接受,且C2与C0压缩强度差异显著(p < 0.05),弯曲强度无显著差异(p > 0.05)。
- C2在24、48和72 h细胞活力与C0相当(p > 0.05),C2较C0抗菌活性显著(p < 0.05)。
临床怎么用
- 低CHX负载浓度(2%)的POSS改性复合树脂具抗菌活性,同时保持可接受力学性能和生物相容性,提示其作为生物活性修复材料的潜在应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of this study was to develop a novel antibacterial dental composite resin by loading chlorhexidine (CHX) onto bioactive glass (BG 45S5) and incorporating it into a resin matrix containing cage-type polyhedral oligomeric silsesquioxane (POSS) nanomonomers. METHODS: CHX was loaded onto the surface of BG 45S5 using a blending method to obtain experimental groups with different CHX concentrations. Experimental composite resins were prepared by incorporating 20 wt% CHX-loaded BG 45S5 and 40 wt% SiO₂ as inorganic fillers into a matrix containing 4 wt% POSS nanomonomer. Materials characterization were performed using Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM), with analysis of double-bond conversion. Mechanical properties were evaluated using a universal testing machine, and fracture mechanisms were analyzed by SEM. In vitro drug release was assessed to determine chlorhexidine release behavior. Biocompatibility was evaluated using CCK-8 assays, acute oral systemic toxicity tests, and oral mucosal irritation tests. Antimicrobial activity was assessed using bacterial growth assays, agar plate counting, and the plate diffusion method. RESULTS: Increasing chlorhexidine concentration resulted in particle agglomeration, reduced double-bond conversion rate, and decreased mechanical strength. Compressive strength of C2 differed significantly from that of C0 (p < 0.05), whereas flexural strength showed no significant difference (p > 0.05). At a chlorhexidine loading concentration of 2 %, the composite resin demonstrated acceptable mechanical properties. In vitro drug release demonstrated an initial rapid release phase followed by a sustained and slower release. Furthermore, CCK-8 assays showed that C2 maintained comparable cell viability to C0 at 24, 48, and 72 h (p > 0.05). In vivo evaluations revealed no significant systemic toxicity or oral mucosal irritation. C2 exhibited significant antibacterial activity compared with C0 (p < 0.05). CONCLUSIONS: Incorporation of 2 % CHX-loaded bioactive glass 45S5 into a POSS-modified composite resin maintained acceptable mechanical performance and provided sustained drug release, biocompatibility, and significant antibacterial activity. CLINICAL SIGNIFICANCE: The modified composite resin with a low CHX loading concentration demonstrated antibacterial activity while maintaining acceptable mechanical performance and biocompatibility, suggesting its potential application as a bioactive restorative material.
引用
- Wei M, Hu Q, Xie Q, et al. Enhanced antimicrobial properties of POSS-modified composite resin with chlorhexidine-loaded bioactive glass. J Dent. 2026. PMID: 41850415. doi:10.1016/j.jdent.2026.106633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。